Iopamidol-300 and Atropine sulfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Iopamidol-300 and Atropine sulfate together.

The phase IV clinical study analyzes what interactions people who take Iopamidol-300 and Atropine sulfate have. It is created by eHealthMe based on reports of 5 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

5 people who take Iopamidol-300 and Atropine sulfate together, and have interactions are studied.


What is Iopamidol-300?

Iopamidol-300 has active ingredients of iopamidol. eHealthMe is studying from 209 Iopamidol-300 users for its effectiveness, alternative drugs and more.

What is Atropine sulfate?

Atropine sulfate has active ingredients of atropine sulfate. eHealthMe is studying from 2,868 Atropine sulfate users for its effectiveness, alternative drugs and more.

Number of Iopamidol-300 and Atropine sulfate reports submitted per year:

Iopamidol-300 and Atropine sulfate drug interactions.

Common Iopamidol-300 and Atropine Sulfate drug interactions by gender *:

female:

  1. Anuria
  2. Blood pressure decreased
  3. Cardiac arrest
  4. Cyanosis
  5. Depressed level of consciousness
  6. Difficulty in walking
  7. Disseminated intravascular coagulation
  8. Dyspnoea
  9. Dystonia
  10. Hypotension

male:

  1. Pyrexia
  2. Sedation
  3. Oedema
  4. Pneumonia
  5. Pupils unequal
  6. Rash pruritic
  7. Blood pressure systolic decreased
  8. Coma
  9. Contrast media reaction
  10. Depressed level of consciousness

Common Iopamidol-300 and Atropine Sulfate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Contrast media reaction
  2. Drug eruption
  3. Hepatic function abnormal
  4. Pyrexia
  5. Rash pruritic

50-59:

  1. Blood pressure systolic decreased
  2. Hypotension
  3. Sedation

60+:

  1. Depressed level of consciousness
  2. Anuria
  3. Hypotension
  4. Malaise
  5. Muscle spasms
  6. Nausea
  7. Oedema
  8. Platelet count decreased
  9. Pneumonia
  10. Pulse pressure decreased

* Approximation only. Some reports may have incomplete information.

Do you take Iopamidol-300 and Atropine sulfate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Iopamidol-300 and Atropine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atropine sulfate interactions:

Browse all interactions between Atropine sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on iopamidol and atropine sulfate (the active ingredients of Iopamidol-300 and Atropine sulfate, respectively), and Iopamidol-300 and Atropine sulfate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Iopamidol-300 and Atropine sulfate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: